Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Immunotherapy Efficacy from Analysis of Pre-treatment Tumor Biopsies

NCT04510129 is registered in ClinicalTrials.gov with Cofactor Genomics, Inc. as lead sponsor.

NCT NCT04510129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04510129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Immunotherapy Efficacy from Analysis of Pre-treatment Tumor Biopsies
Lead sponsor
Cofactor Genomics, Inc.
Phase
Observational
Overall status
Recruiting
Start date
February 5, 2020
Completion date
February 28, 2027
Enrollment
1,650 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of head and neck, cervical cancer, colorectal cancer, esophageal squamous cell carcinoma, gastroesophageal junction adenocarcinoma, hepatocellular carcinoma, lung cancer, nonsmall cell, renal cell carcinoma, small-cell lung cancer, triple negative breast cancer, urothelial carcinoma